{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:41:23Z","timestamp":1793313683748,"version":"4.5.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"10","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,28]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>The hallmark of multiple myeloma (MM) is a clonal plasma cell infiltration in the bone marrow accompanied by myelosuppression and osteolysis. Premalignant stages such as monoclonal gammopathy of undetermined significance (MGUS) and asymptomatic stages such as smoldering myeloma (SMM) can progress to MM. Mesenchymal stromal cells (MSCs) are an integral component of the bone marrow microenvironment and play an important role in osteoblast differentiation and hematopoietic support. Although stromal alterations have been reported in MM contributing to hematopoietic insufficiency and osteolysis, it is not clear whether alterations in MSC already occur in MGUS or SMM. In this study, we analyzed MSCs from MGUS, SMM, and MM regarding their properties and functionality and performed messenger RNA sequencing to find underlying molecular signatures in different disease stages. A high number of senescent cells and a reduced osteogenic differentiation capacity and hematopoietic support were already present in MGUS MSC. As shown by RNA sequencing, there was a broad spectrum of differentially expressed genes including genes of the BMP\/TGF-signaling pathway, detected already in MGUS and that clearly increases in patients with SMM and MM. Our data may help to block these signaling pathways in the future to hinder progression to MM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011632","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T20:01:17Z","timestamp":1705694477000},"page":"2575-2588","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma"],"prefix":"10.1182","volume":"8","author":[{"given":"Lucienne","family":"Bogun","sequence":"first","affiliation":[{"name":"1Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Koch","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3738-4979","authenticated-orcid":false,"given":"Bo","family":"Scherer","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Fenk","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Maus","sequence":"additional","affiliation":[{"name":"2Department of Orthopedic Surgery and Traumatology, University Hospital Duesseldorf, Medical Faculty, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5919-3375","authenticated-orcid":false,"given":"Felix","family":"Bormann","sequence":"additional","affiliation":[{"name":"3Bioinformatics.Expert UG, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3644-2022","authenticated-orcid":false,"given":"Karl","family":"K\u00f6hrer","sequence":"additional","affiliation":[{"name":"4Biological and Medical Research Center, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-5524","authenticated-orcid":false,"given":"Patrick","family":"Petzsch","sequence":"additional","affiliation":[{"name":"4Biological and Medical Research Center, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6760-2458","authenticated-orcid":false,"given":"Thorsten","family":"Wachtmeister","sequence":"additional","affiliation":[{"name":"4Biological and Medical Research Center, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3721-6820","authenticated-orcid":false,"given":"Romans","family":"Zukovs","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Dietrich","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Haas","sequence":"additional","affiliation":[{"name":"5Institute of Medical Microbiology and Hospital Hygiene, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schroeder","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9250-2064","authenticated-orcid":false,"given":"Paul","family":"J\u00e4ger","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Geyh","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"issue":"18","key":"2024052815211473700_bib1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"2024052815211473700_bib2","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Kyle","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2024052815211473700_bib3","first-page":"58","article-title":"Haematology: multiple myeloma","volume":"19","author":"Medical Masterclass, e.b.J.F","year":"2019","journal-title":"Clin Med (Lond)"},{"issue":"9727","key":"2024052815211473700_bib4","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"issue":"13","key":"2024052815211473700_bib5","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"2024052815211473700_bib6","doi-asserted-by":"crossref","first-page":"102284","DOI":"10.1016\/j.ctrv.2021.102284","article-title":"Roadmap to cure multiple myeloma","volume":"100","author":"Rodriguez-Otero","year":"2021","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"2024052815211473700_bib7","first-page":"373","article-title":"Multiple myeloma: diagnosis and treatment","volume":"95","author":"Michels","year":"2017","journal-title":"Am Fam Physician"},{"issue":"4","key":"2024052815211473700_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"1","key":"2024052815211473700_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2013.10.002","article-title":"Regulation of hematopoietic stem cells by bone marrow stromal cells","volume":"35","author":"Anthony","year":"2014","journal-title":"Trends Immunol"},{"issue":"7483","key":"2024052815211473700_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"issue":"13","key":"2024052815211473700_bib11","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood-2011-04-347484","article-title":"Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells","volume":"120","author":"Bruns","year":"2012","journal-title":"Blood"},{"issue":"26","key":"2024052815211473700_bib12","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International staging system for multiple myeloma: a report from International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"2024052815211473700_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/leu.2013.247","article-title":"IMWG consensus on risk stratification in multiple myeloma","volume":"28","author":"Chng","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"2024052815211473700_bib14","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/leu.2013.193","article-title":"Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells","volume":"27","author":"Geyh","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"2024052815211473700_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/leu.2015.325","article-title":"Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia","volume":"30","author":"Geyh","year":"2016","journal-title":"Leukemia"},{"issue":"9","key":"2024052815211473700_bib16","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/stem.3387","article-title":"Acute myeloid leukemia-induced functional inhibition of healthy CD34+ hematopoietic stem and progenitor cells","volume":"39","author":"Jager","year":"2021","journal-title":"Stem Cells"},{"issue":"1","key":"2024052815211473700_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"3","key":"2024052815211473700_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"9","key":"2024052815211473700_bib19","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3324\/haematol.2017.186734","article-title":"Transforming growth factor beta1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia","volume":"103","author":"Geyh","year":"2018","journal-title":"Haematologica"},{"issue":"10","key":"2024052815211473700_bib20","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1158\/0008-5472.CAN-17-3115","article-title":"From MGUS to multiple myeloma, a paradigm for clonal evolution of premalignant cells","volume":"78","author":"van Nieuwenhuijzen","year":"2018","journal-title":"Cancer Res"},{"issue":"2","key":"2024052815211473700_bib21","first-page":"160","article-title":"The analysis of the relationship between multiple myeloma cells and their microenvironment","volume":"6","author":"Jurczyszyn","year":"2015","journal-title":"J\u00a0Cancer"},{"issue":"2","key":"2024052815211473700_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7150\/ijbs.2929","article-title":"TGF-beta and BMP signaling in osteoblast differentiation and bone formation","volume":"8","author":"Chen","year":"2012","journal-title":"Int J Biol Sci"},{"issue":"4","key":"2024052815211473700_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-beta signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"2024052815211473700_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1210\/endo.137.1.8536632","article-title":"Immortalized murine osteoblasts derived from BMP 2-T-antigen expressing transgenic mice","volume":"137","author":"Ghosh-Choudhury","year":"1996","journal-title":"Endocrinology"},{"issue":"1","key":"2024052815211473700_bib25","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1038\/s41467-019-12296-1","article-title":"Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease","volume":"10","author":"Gooding","year":"2019","journal-title":"Nat Commun"},{"key":"2024052815211473700_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.22203\/eCM.v028a19","article-title":"Role and regulation of Runx2 in osteogenesis","volume":"28","author":"Bruderer","year":"2014","journal-title":"Eur Cell Mater"},{"issue":"2","key":"2024052815211473700_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1078-0432.CCR-11-2212","article-title":"Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects","volume":"18","author":"Reagan","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2024052815211473700_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.exphem.2009.11.009","article-title":"Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease","volume":"38","author":"Todoerti","year":"2010","journal-title":"Exp Hematol"},{"issue":"18","key":"2024052815211473700_bib29","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.18632\/oncotarget.2058","article-title":"Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease","volume":"5","author":"Garcia-Gomez","year":"2014","journal-title":"Oncotarget"},{"issue":"26","key":"2024052815211473700_bib30","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"2024052815211473700_bib31","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41419-019-1959-5","article-title":"TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma","volume":"10","author":"Giallongo","year":"2019","journal-title":"Cell Death Dis"},{"key":"2024052815211473700_bib32","doi-asserted-by":"crossref","first-page":"1059715","DOI":"10.3389\/fcell.2022.1059715","article-title":"Targeting TGF-beta signaling in the multiple myeloma microenvironment: steering CARs and T cells in the right direction","volume":"10","author":"Rana","year":"2022","journal-title":"Front Cell Dev Biol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/10\/2575\/2226586\/blooda_adv-2023-011632-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/10\/2575\/2226586\/blooda_adv-2023-011632-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T18:10:37Z","timestamp":1716919837000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/10\/2575\/514676\/Stromal-alterations-in-patients-with-monoclonal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,5,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011632","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]}}}